TD-4208 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects
Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the absorption, distribution, metabolism and
excretion of an investigational medication used to treat chronic obstructive pulmonary
disease (COPD). The study drug will be tested in 6 healthy normal males. Dosing will include
a single dose of study drug administered via an IV Infusion and an Oral Dose. There will be a
28 day washout period between each of the 2 dosing routes.